Outcomes of non-operated patients at the end of the study period
| Clinical deterioration and radiological progression | Clinical deterioration without radiological progression | Radiological progression without clinical deterioration | New-onset disease, non-related to COVID-19 | Non-deterioration | Death | |
| Oncology | 1 (1.7%) | 2 (3.4%) | 0 | 1 (1.7%) | 53 (91.4%) | 1 (1.7%) |
| Degenerative spine | 12 (2.6%) | 110 (23.4%) | 5 (1.1%) | 16 (3.4%) | 326 (69.4%) | 1 (0.2%) |
| TBI | 0 | 1 (20%) | 0 | 0 | 4 (80%) | 0 |
| Haemorrhagic cerebrovascular disease | 1 (5.9%) | 0 | 0 | 3 (17.6%) | 13 (76.5%) | 0 |
| CSF | 0 | 10 (40%) | 0 | 2 (8%) | 13 (52%) | 0 |
| Functional | 0 | 34 (39.5%) | 0 | 3 (3.5%) | 49 (57%) | 0 |
| Traumatic spine disease | 0 | 1 (16.7%) | 0 | 1 (16.7%) | 4 (66.7%) | 0 |
| Infectious | 0 | 0 | 1 (50%) | 0 | 1 (50%) | 0 |
| Paediatric | 0 | 1 (0.1%) | 0 | 0 | 10 (90.9%) | 0 |
CSF, cerebrospinal fluid; TBI, traumatic brain injury.